Serum Leads Way With Heat-Stable Rotavirus Vaccine But Competition Unfazed

Serum Institute has launched a cut-price oral thermostable rotavirus vaccine in India, but competitors like Hilleman Labs, also developing a heat-stable vaccine in the area, aren’t losing much sleep, for now at least. Serum has also introduced a rabies monoclonal antibody.

Pharmaceutical production
SERUM HAS LAUNCHED A HEAT-STABLE ROTAVIRUS VACCINE

Serum Institute of India Ltd.’s new thermostable pentavalent rotavirus vaccine is expected to create a flutter in the market given its price point and first-of-its-kind tag. Competitors like Hilleman Labs, which is also developing a heat-stable rotavirus vaccine, appear unperturbed, however, and claim marked differentiation for their products.

Serum has also launched a recombinant rabies monoclonal antibody, developed in a research partnership with the Massachusetts Medical School, US.

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip